KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $4.6 million.

  • Astrana Health's Tax Provisions fell 4133.57% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year decrease of 3574.07%. This contributed to the annual value of $35.1 million for FY2024, which is 2092.36% down from last year.
  • According to the latest figures from Q3 2025, Astrana Health's Tax Provisions is $4.6 million, which was down 4133.57% from $6.6 million recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Tax Provisions ranged from a high of $28.2 million in Q2 2021 and a low of -$4.3 million during Q4 2021
  • In the last 5 years, Astrana Health's Tax Provisions had a median value of $7.8 million in 2024 and averaged $8.8 million.
  • As far as peak fluctuations go, Astrana Health's Tax Provisions plummeted by 13523.89% in 2021, and later surged by 639202.9% in 2022.
  • Astrana Health's Tax Provisions (Quarter) stood at -$4.3 million in 2021, then skyrocketed by 365.03% to $11.3 million in 2022, then rose by 18.73% to $13.5 million in 2023, then fell by 24.74% to $10.1 million in 2024, then plummeted by 54.66% to $4.6 million in 2025.
  • Its Tax Provisions stands at $4.6 million for Q3 2025, versus $6.6 million for Q2 2025 and $3.4 million for Q1 2025.